Evidence for opioid receptors on cells involved in host defense and the immune system

Burt M. Sharp, Sabita Roy, Jean M. Bidlack

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Although the role of opiates and opioids in the physiological and pathological function of the immune system is only beginning to be unraveled, converging lines of evidence indicate that the opioid receptors expressed by immune cells are often the same or similar to the neuronal subtypes, particularly δ and κ. Recent studies also point to the existence of novel opioid receptors and/or binding sites on immune cells that are selective for morphine. Opioids and their receptors, particularly those with high affinity for δ agonists, appear to function in an autocrine/paracrine manner. Thus, opioid peptides generated from immune-derived proenkephalin A act as cytokines, capable of regulating myriad functions of both granulocytes and mononuclear cells. Further identification and characterization of receptors and signal transduction pathways that account for some of the unique properties of opiate binding and immunomodulation (e.g., dose-dependent effects of morphine that occur at exceptionally low concentrations relative to the K(d)'s of the neuronal μ receptor or the morphine binding site reported on activated human T-cells) represents one of the major research challenges ahead. Elucidating mechanisms, such as these, may provide unique therapeutic opportunities through the application of opioid immunopharmacology to disorders involving immune responses in peripheral organs and the central nervous system.

Original languageEnglish (US)
Pages (from-to)45-56
Number of pages12
JournalJournal of Neuroimmunology
Volume83
Issue number1-2
DOIs
StatePublished - Mar 15 1998
Externally publishedYes

Fingerprint

Opiate Alkaloids
Opioid Receptors
Immune System
Morphine
Opioid Analgesics
Binding Sites
Opioid Peptides
Immunomodulation
mu Opioid Receptor
Immune System Diseases
Granulocytes
Signal Transduction
Central Nervous System
Cytokines
T-Lymphocytes
Research
Therapeutics

Keywords

  • Delta
  • Kappa
  • Mu

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Evidence for opioid receptors on cells involved in host defense and the immune system. / Sharp, Burt M.; Roy, Sabita; Bidlack, Jean M.

In: Journal of Neuroimmunology, Vol. 83, No. 1-2, 15.03.1998, p. 45-56.

Research output: Contribution to journalArticle

@article{cce74baa2cae42ceb7ed82f2d505395f,
title = "Evidence for opioid receptors on cells involved in host defense and the immune system",
abstract = "Although the role of opiates and opioids in the physiological and pathological function of the immune system is only beginning to be unraveled, converging lines of evidence indicate that the opioid receptors expressed by immune cells are often the same or similar to the neuronal subtypes, particularly δ and κ. Recent studies also point to the existence of novel opioid receptors and/or binding sites on immune cells that are selective for morphine. Opioids and their receptors, particularly those with high affinity for δ agonists, appear to function in an autocrine/paracrine manner. Thus, opioid peptides generated from immune-derived proenkephalin A act as cytokines, capable of regulating myriad functions of both granulocytes and mononuclear cells. Further identification and characterization of receptors and signal transduction pathways that account for some of the unique properties of opiate binding and immunomodulation (e.g., dose-dependent effects of morphine that occur at exceptionally low concentrations relative to the K(d)'s of the neuronal μ receptor or the morphine binding site reported on activated human T-cells) represents one of the major research challenges ahead. Elucidating mechanisms, such as these, may provide unique therapeutic opportunities through the application of opioid immunopharmacology to disorders involving immune responses in peripheral organs and the central nervous system.",
keywords = "Delta, Kappa, Mu",
author = "Sharp, {Burt M.} and Sabita Roy and Bidlack, {Jean M.}",
year = "1998",
month = "3",
day = "15",
doi = "10.1016/S0165-5728(97)00220-8",
language = "English (US)",
volume = "83",
pages = "45--56",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Evidence for opioid receptors on cells involved in host defense and the immune system

AU - Sharp, Burt M.

AU - Roy, Sabita

AU - Bidlack, Jean M.

PY - 1998/3/15

Y1 - 1998/3/15

N2 - Although the role of opiates and opioids in the physiological and pathological function of the immune system is only beginning to be unraveled, converging lines of evidence indicate that the opioid receptors expressed by immune cells are often the same or similar to the neuronal subtypes, particularly δ and κ. Recent studies also point to the existence of novel opioid receptors and/or binding sites on immune cells that are selective for morphine. Opioids and their receptors, particularly those with high affinity for δ agonists, appear to function in an autocrine/paracrine manner. Thus, opioid peptides generated from immune-derived proenkephalin A act as cytokines, capable of regulating myriad functions of both granulocytes and mononuclear cells. Further identification and characterization of receptors and signal transduction pathways that account for some of the unique properties of opiate binding and immunomodulation (e.g., dose-dependent effects of morphine that occur at exceptionally low concentrations relative to the K(d)'s of the neuronal μ receptor or the morphine binding site reported on activated human T-cells) represents one of the major research challenges ahead. Elucidating mechanisms, such as these, may provide unique therapeutic opportunities through the application of opioid immunopharmacology to disorders involving immune responses in peripheral organs and the central nervous system.

AB - Although the role of opiates and opioids in the physiological and pathological function of the immune system is only beginning to be unraveled, converging lines of evidence indicate that the opioid receptors expressed by immune cells are often the same or similar to the neuronal subtypes, particularly δ and κ. Recent studies also point to the existence of novel opioid receptors and/or binding sites on immune cells that are selective for morphine. Opioids and their receptors, particularly those with high affinity for δ agonists, appear to function in an autocrine/paracrine manner. Thus, opioid peptides generated from immune-derived proenkephalin A act as cytokines, capable of regulating myriad functions of both granulocytes and mononuclear cells. Further identification and characterization of receptors and signal transduction pathways that account for some of the unique properties of opiate binding and immunomodulation (e.g., dose-dependent effects of morphine that occur at exceptionally low concentrations relative to the K(d)'s of the neuronal μ receptor or the morphine binding site reported on activated human T-cells) represents one of the major research challenges ahead. Elucidating mechanisms, such as these, may provide unique therapeutic opportunities through the application of opioid immunopharmacology to disorders involving immune responses in peripheral organs and the central nervous system.

KW - Delta

KW - Kappa

KW - Mu

UR - http://www.scopus.com/inward/record.url?scp=0032520701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032520701&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(97)00220-8

DO - 10.1016/S0165-5728(97)00220-8

M3 - Article

C2 - 9610672

AN - SCOPUS:0032520701

VL - 83

SP - 45

EP - 56

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -